3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Neoplasms
4
Prostatic Neoplasms
2
Motor Activity
2
Breast Neoplasms
2
Urologic Neoplasms
1
Testicular Neoplasms
1
Sleep Initiation and Maintenance Disorders
1
Sarcoma
1
Resectable Lung Non-Small Cell Carcinoma
1
Rectal Neoplasms
1
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
1
Penile Neoplasms
1
Pancreatic Neoplasms
1
Pain
1
Neuromuscular Diseases
1
Neoplasm Metastasis
1
Myotonic Dystrophy
1
Myositis, Inclusion Body
1
Muscular Dystrophy, Facioscapulohumeral
1
Muscular Dystrophies, Limb-Girdle
1
Muscular Atrophy, Spinal
1
Multiple Myeloma
1
Lymphoma, B-Cell
1
Lymphedema
1
Lung Neoplasms
1
Low Anterior Resection Syndrome
1
Lambert-Eaton Myasthenic Syndrome
1
Kidney Neoplasms
1
Hereditary Sensory and Motor Neuropathy
1
Guillain-Barre Syndrome
1
Interventions
Paclitaxel
15
liposomal doxorubicin
8
Carboplatin
8
Bevacizumab
8
pembrolizumab
7
Topotecan
6
olaparib
4
mirvetuximab soravtansine
4
Nivolumab
4
Cyclophosphamide
4
niraparib
3
fludarabine
3
Gemcitabine
3
Drug Therapy
3
rucaparib
2
ribociclib
2
pegfilgrastim
2
palbociclib
2
oregovomab
2
fludarabine phosphate
2
Irinotecan
2
Hyperthermic Intraperitoneal Chemotherapy
2
Fulvestrant
2
Cisplatin
2
Blood Specimen Collection
2
1-dodecylpyridoxal
2
trastuzumab deruxtecan
1
sacituzumab govitecan
1
isoquercitrin
1
irinotecan sucrosofate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Carcinoma, Ovarian Epithelial
×
Physical Therapy Modalities
×
1 year
×
Clear all
No trials found.